beta erythropoietin
Recombinant proteinexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2009 (NCT00495547)
Timeline
Indications
Mechanism of action
- ErythropoietinSupplementation
EPO supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- beta erythropoietin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01066351 | Phase 3 | Jan 1, 2010 | Thammasat University |
| NCT00495547 | Phase 2 | Feb 1, 2009 | Celgene, PETHEMA Foundation, Roche, University of Salamanca, University of Valencia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celgene | For profit | 1 | 0 | 1 | 2009 |
| PETHEMA Foundation | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Roche | For profit | 1 | 0 | 1 | 2009 |
| Thammasat University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Salamanca | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2009 |
6 organizations
Page 1 / 1